Precision Diabetes and DirectSens to introduce MetMark test in US

​

Precision Diabetes has signed a US commercialisation partnership with DirectSens for the MetMark clinical test, which measures AHB; 2-HB, a biomarker associated with metabolic dysfunction and future type 2 diabetes risk.

The post Precision Diabetes and DirectSens to introduce MetMark test in US appeared first on Hospital Management.

 

Back to the Featured Stories

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.